Pancreatic ductal adenocarcinoma (PAAD) harboured the most KRAS mutations (73%), followed by COAD (48%), rectum adenocarcinoma [READ] (38%), LUAD (30%), and UCEC (18%, Fig. 6d). This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.